Henry Schein, Inc., headquartered in Melville, N.Y., is a leading provider of healthcare products and services to office-based dental and medical practitioners. Founded by Henry Schein and Esther Schein in 1932, the company is now led by Stanley M. Bergman and has more than 19,000 employees worldwide. It serves more than one million customers globally.
Henry Schein’s operations are organized into two principal segments: healthcare distribution and technology. The healthcare distribution segment distributes consumables products, lab products, services, equipment, vaccines, pharmaceuticals, and surgical products. The technology segment provides software, technology, and other value-added services to its healthcare practitioners.
The company has a well-established reputation for being customer-centric. Henry Schein’s operations are guided by the belief in "doing well by doing good." It aids its customers to operate efficient practices while delivering high-quality care by providing a broad array of solutions, delivered by committed team Schein members.
What sets Henry Schein apart is its strong supply chain network, which spans North America, Europe, and the Asia-Pacific region. The company’s strong global footprint empowers it to reach more customers and tap into new markets. Its extensive product portfolio covers both generic and specialty drugs.
Henry Schein is also deeply invested in the communities it serves. Through its Henry Schein Cares program, the company funds various charitable initiatives globally that focus on increasing access to healthcare for underserved populations.
Furthermore, the company’s commitment towards sustainability is evident from its participation in eco-conscious initiatives. Henry Schein, Inc. is keen on promoting resource efficiency in its operations and reducing its carbon footprint with programs like the Henry Schein Green initiative.
The company operates under high standards of corporate governance and social responsibility, dedicating considerable resources to ethics and compliance programs. Henry Schein, Inc. is not only dedicated to its mission of delivering the best health to healthcare professionals—they go a step further to ensure the well-being and progress of communities surrounding their fields of operation.
Despite the challenges posed by the volatile economic environment, Henry Schein continues to show steady growth both organically and through strategic acquisitions. Its stock is listed on the NASDAQ Stock Market under the symbol "HSIC". Notably, it was also named as a Fortune World’s Most Admired Company for three consecutive years, from 2016-2018, a testament to its reliable business model and management caliber.